The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Global Cardiovascular and Renal Outcomes of Reduced GFR
Open accessAbstract
The burden of premature death and health loss from ESRD is well described. Less is known regarding the burden of cardiovascular disease attributable to reduced GFR. We estimated the prevalence of reduced GFR categories 3, 4, and 5 (not on RRT) for 188 countries at six time points from 1990 to 2013. Relative risks of cardiovascular outcomes by three categories of reduced GFR were calculated by pooled random effects meta-analysis. Results are presented as deaths for outcomes of cardiovascular disease and ESRD and as disability-adjusted life years for outcomes of cardiovascular disease, GFR categories 3, 4, and 5, and ESRD. In 2013, reduced GFR was associated with 4% of deaths worldwide, or 2.2 million deaths (95% uncertainty interval [95% UI], 2.0 to 2.4 million). More than half of these attributable deaths were cardiovascular deaths (1.2 million; 95% UI, 1.1 to 1.4 million), whereas 0.96 million (95% UI, 0.81 to 1.0 million) were ESRD-related deaths. Compared with metabolic risk factors, reduced GFR ranked below high systolic BP, high body mass index, and high fasting plasma glucose, and similarly with high total cholesterol as a risk factor for disability-adjusted life years in both developed and developing world regions. In conclusion, by 2013, cardiovascular deaths attributed to reduced GFR outnumbered ESRD deaths throughout the world. Studies are needed to evaluate the benefit of early detection of CKD and treatment to decrease these deaths.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Self-citationChronic kidney disease: global dimension and perspectives
Jha, V., Garcia-Garcia, G., Iseki, K., Li, Z., Naicker, S., Plattner, B., Saran, R., Wang, A. Y.-M., & Yang, C.-W. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60687-x · Cited by 4,383
Self-citationGlobal nutrition transition and the pandemic of obesity in developing countries
Popkin, B. M., Adair, L. S., & Ng, S. W. (2012) · Nutrition Reviews · doi:10.1111/j.1753-4887.2011.00456.x · Cited by 4,313
Baigent, C., Landray, M. J., Reith, C., Emberson, J., Wheeler, D. C., Tomson, C., Wanner, C., Krane, V., Cass, A., Craig, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60739-3 · Cited by 2,479
PROPORTION OF DISEASE CAUSED OR PREVENTED BY A GIVEN EXPOSURE, TRAIT OR INTERVENTION1
MIETTINEN, O. S. (1974) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a121617 · Cited by 1,036
Xie, X., Atkins, E., Lv, J., Bennett, A., Neal, B., Ninomiya, T., Woodward, M., MacMahon, S., Turnbull, F., Hillis, G. S., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00805-3 · Cited by 980
Ene-Iordache, B., Perico, N., Bikbov, B., Carminati, S., Remuzzi, A., Perna, A., Islam, N., Bravo, R. F., Aleckovic-Halilovic, M., Zou, H., et al. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)00071-1 · Cited by 627
Self-citation
Cited by
Chronic kidney disease and the global public health agenda: an international consensus
Francis, A., Harhay, M. N., Ong, A. C. M., Tummalapalli, S. L., Ortiz, A., Fogo, A. B., Fliser, D., Roy-Chaudhury, P., Fontana, M., Nangaku, M., et al. (2024) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00820-6 · Cited by 1,374
Self-citationTargeting the progression of chronic kidney disease
Ruiz-Ortega, M., Rayego-Mateos, S., Lamas, S., Ortiz, A., & Rodrigues-Diez, R. R. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0248-y · Cited by 979
Self-citationKhan, S. S., Coresh, J., Pencina, M. J., Ndumele, C. E., Rangaswami, J., Chow, S. L., Palaniappan, L. P., Sperling, L. S., Virani, S. S., Ho, J. E., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001191 · Cited by 797
Self-citationThe 2016 global and national burden of diabetes mellitus attributable to PM 2·5 air pollution
Bowe, B., Xie, Y., Li, T., Yan, Y., Xian, H., & Al-Aly, Z. (2018) · The Lancet Planetary Health · doi:10.1016/s2542-5196(18)30140-2 · Cited by 371
Self-citation
Metadata
- Authors
- Thomas, B., Matsushita, K., Abate, K. H., Al-Aly, Z., Ärnlöv, J., Asayama, K., Atkins, R., Badawi, A., Ballew, S. H., Banerjee, A., Barregård, L., Barrett-Connor, E., Basu, S., Bello, A. K., Bensenor, I., Bergstrom, J., Bikbov, B., Blosser, C., Brenner, H., Carrero, J.-J., Chadban, S., Cirillo, M., Cortinovis, M., Courville, K., Dandona, L., Dandona, R., Estep, K., Fernandes, J., Fischer, F., Fox, C., Gansevoort, R. T., Gona, P. N., Gutierrez, O. M., Hamidi, S., Hanson, S. W., Himmelfarb, J., Jassal, S. K., Jee, S. H., Jha, V., Jimenez-Corona, A., Jonas, J. B., Kengne, A. P., Khader, Y., Khang, Y.-H., Kim, Y. J., Klein, B., Klein, R., Kokubo, Y., Kolte, D., Lee, K., Levey, A. S., Li, Y., Lotufo, P., El Razek, H. M. A., Mendoza, W., Metoki, H., Mok, Y., Muraki, I., Muntner, P. M., Noda, H., Ohkubo, T., Ortiz, A., Perico, N., Polkinghorne, K., Al-Radaddi, R., Remuzzi, G., Roth, G., Rothenbacher, D., Satoh, M., Saum, K.-U., Sawhney, M., Schöttker, B., Shankar, A., Shlipak, M., Silva, D. A. S., Toyoshima, H., Ukwaja, K., Umesawa, M., Vollset, S. E., Warnock, D. G., Werdecker, A., Yamagishi, K., Yano, Y., Yonemoto, N., Zaki, M. E. S., Naghavi, M., Forouzanfar, M. H., Murray, C. J. L., Coresh, J., Vos, T., Collaborators, O. B. O. T. G. B. O. D. 2. G., CKD Prognosis Consortium, & Global Burden of Disease Genitourinary Expert Group
- Venue
- Journal of the American Society of Nephrology
- Published
- 2017-04-13
- Volume
- 28
- Issue
- 7
- Pages
- 2167-2179
- ISSN
- 1046-6673 (ISSN-L)
- 1533-3450
- OpenAlex
- W2606924046
- Cited by
- 266
- References
- 7
- FWCI
- 20.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Global Cardiovascular and Renal Outcomes of Reduced GFR. https://app.cochat.ai/papers/10.1681/asn.2016050562
- The paper
- Thomas, B., Matsushita, K., Abate, K. H., Al-Aly, Z., Ärnlöv, J., Asayama, K., Atkins, R., Badawi, A., Ballew, S. H., Banerjee, A., Barregård, L., Barrett-Connor, E., Basu, S., Bello, A. K., Bensenor, I., Bergstrom, J., Bikbov, B., Blosser, C., Brenner, H., . . . Global Burden of Disease Genitourinary Expert Group. (2017). Global Cardiovascular and Renal Outcomes of Reduced GFR. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.2016050562
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.